Differential modulation of agonist and antagonist structure activity relations for rat TRPV1 by cyclosporin A and other protein phosphatase inhibitors

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 377, Issue 2, 2008, Pages 149-157

  Pearce, Larry V ^a   Toth, Attila ^a,b   Ryu, HyungChul ^c   Kang, Dong Wook ^c   Choi, Hyun Kyung ^c   Jin, Mi Kyoung ^c   Lee, Jeewoo ^c   Blumberg, Peter M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c Seoul National University   (South Korea)

Author keywords

Capsaicin; Cyclosporin A; Protein phosphatase; Resiniferatoxin; TRPV1; Vanilloid

Indexed keywords

4 CHLORO N (3 METHOXYPHENYL)CINNAMAMIDE; AMG 9810; CALCINEURIN; CALYCULIN A; CAPSAICIN; CAPSAVANIL; CHK 679; CYCLOSPORIN A; EVODIAMINE; OKADAIC ACID; OLVANIL; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; PSY 279; RESINIFERATOXIN; TACROLIMUS; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1;

AGONIST; ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; NERVE FIBER C; NONHUMAN; PHOSPHORYLATION; STATISTICAL ANALYSIS; STRUCTURE ACTIVITY RELATION;

ANIMALS; CALCIUM; CAPSAICIN; CHO CELLS; CRICETINAE; CRICETULUS; CYCLOSPORINE; ENZYME INHIBITORS; PHOSPHOPROTEIN PHOSPHATASES; RATS; STRUCTURE-ACTIVITY RELATIONSHIP; TRPV CATION CHANNELS;

EID: 41049100252     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-007-0258-3     Document Type: Article

References (41)

1. Bailie GR, Eisele G (1990) Cyclosporine-associated arthralgia. Clin Nephrol 33:256-267
2. Bhave G, Zhu W, Wang H, Brasier DJ, Oxford GS, Gereau RW 4th (2002) cAMP-dependent protein kinase regulates desensitization of the capsaicin receptor (VR1) by direct phosphorylation. Neuron 35:721-731
3. Bhave G, Hu HJ, Glauner KS, Zhu W, Wang H, Brasier DJ, Oxford GS, Gereau RW 4th (2003) Protein Kinase C phosphorylation sensitizes but does not activate capsaicin receptor transient potential receptor vanilloid 1 (TRPV1). Proc Natl Acad Sci U S A 100:12480-12485
4. Chuang HH, Prescott ED, Kong H, Shields S, Jordt SE, Basbaum AI, Chao MV, Julius D (2001) Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition. Nature 411:957-962
5. Clipstone NA, Crabtree GR (1992) Identification of calcineurin as a key signaling enzyme in T-lymphocyte activation. Nature 357:695-697
6. Cortright DN, Szallasi Z (2004) Biochemical pharmacology of the vanilloid receptor TRPV1. An update. Eur J Biochem 271:1814-1819
7. Di Marzo V, Blumberg PM, Szallasi A (2002) Endovanilloid signaling in pain. Curr Opin Neurobiol 12:372-379
8. Docherty RJ, Yeats JC, Bevan S, Boddeke HW (1996) Inhibition of calcineurin inhibits the desensitization of capsaicin-evoked currents in cultured dorsal root ganglion neurons from adult rats. Pflugers Arch 431:828-837
9. Favre B, Turowski P, Hemmings BA (1997) Differential inhibition and posttranslational modification of protein phosphatase 1 and 2A in MCF7 cells treated with calyculin-A, okadaic acid, and tautomycin. J Biol Chem 272:13856-13863
10. Galoyan SM, Petruska JC, Mendell LM (2003) Mechanisms of sensitization of the response of single dorsal root ganglion cells from adult rat to noxious heat. Eur J Neurosci 18:535-541
11. Gavva NR, Bannon AW, Surapaneni S, Hovland DN Jr, Lehto SG, Gore A, Juan T, Deng H, Han B, Klionsky L, Kuang R, Le A, Tamir R, Wang J, Youngblood B, Zhu D, Norman MH, Magal E, Treanor JJS, Louis JC (2007) The vanilloid receptor TRPV1 is tonically activated in vivo and involved in body temperature regulation. J Neurosci 27:3366-3374
12. Hori M, Magae J, Han YG, Hartshorne DJ, Karaki H (1991) A novel protein phosphatase inhibitor, tautomycin. Effect on smooth muscle.. FEBS Lett 285:145-148
13. Ishihara H, Martin BL, Brautigan DL, Karaki H, Ozaki H, Kato Y, Fusetani N, Watabe S, Hashimoto K, Uemura D, Hartshorne DJ (1989) Calyculin A and okadaic acid: inhibitors of protein phosphatase activity. Biochem Biophys Res Commun 159:871-877
14. Jin X, Morsy N, Winston J, Pasricha PJ, Garrett K, Akbarali HI (2004) Modulation of TRPV1 by nonreceptor tyrosine kinase, c-Src kinase. Am J Physiol Cell Physiol 287:C558-C563
15. Jordt SE, Tominaga M, Julius D (2000) Acid potentiation of the capsaicin receptor determined by a key extracellular site. Proc Natl Acad Sci U S A 97:8134-8139
16. Julius D, Basbaum AI (2001) Molecular mechanisms of nociception. Nature 413:203-210
17. Jung J, Hwang SW, Kwak J, Lee SY, Kang CJ, Kim WB, Kim D, Oh U (1999) Capsaicin binds to the intracellular domain of the capsaicin-activated ion channel. J Neurosci 19:529-538
18. Jung J, Shin JS, Lee SY, Hwang SW, Koo J, Cho H, Oh U (2004) Phosphorylation of vanilloid receptor 1 by Ca2+/calmodulin-dependent kinase II regulates its vanilloid binding. J Biol Chem 279:7048-7054
19. Krause JE, Chenard BL, Cortright DN (2005) Transient receptor potential ion channels as targets for the discovery of pain therapeutics. Curr Opin Investig Drugs 6:48-57
20. Lazar J, Braun DC, Toth A, Wang Y, Pearce LV, Pavlyukovets VA, Blumberg PM, Garfield SH, Wincovitch S, Choi HK, Lee J (2006) Kinetics of penetration influence the apparent potency of vanilloids on TRPV1. Mol Pharmacol 69:1166-1173
21. Liu J, Farmer JD Jr, Lane WS, Friedman J, Weissman I, Schreiber SL (1991) Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66:807-815
22. Lizanecz E, Bagi Z, Pasztor ET, Papp Z, Edes I, Kedei N, Blumberg PM, Toth A (2006) Phosphorylation-dependent desensitization by anandamide of vanilloid receptor-1 (TRPV1) function in rat skeletal muscle arterioles and in Chinese hamster ovary cells expressing TRPV1. Mol Pharmacol 69:1015-1023
23. Mohapatra DP, Nau C (2005) Regulation of Ca2+dependent desensitization in the vanilloid receptor TRPV1 by calcineurin and cAMP-dependent protein kinase. J Biol Chem 280:13424-13432
24. Nagy I, Santha P, Jancso G, Urban L (2004) The role of the vanilloid (capsaicin) receptor (TRPV1) in physiology and pathology. Eur J Pharmacol 500:351-369
25. Ponticelli C, Campise MR (2005) Neurological complications in kidney transplant recipients. J Nephrol 18:521-528
26. Prescott ED, Julius D (2003) A modular PIP2 binding site as a determinant of capsaicin receptor sensitivity. Science 300:1284-1288
27. Robbins W (2000) Clinical applications of capsaicinoids. Clin J Pain 16:S86-S89
28. Silva C, Ribeiro MJ, Cruz F (2002) The effect of intravesical resiniferatoxin in patients with idiopathic detrusor instability suggests that involuntary detrusor contractions are triggered by C-fiber input. J Urol 168:575-579
29. Stein AT, Ufret-vincenty CA, Hua L, Santan LF, Gordon SE (2006) Phosphoinositide 3-kinase binds to TRPV1 and mediates NGF-stimulated TRPV1 trafficking to the plasma membrane. J Gen Physiol 128:509-522
30. Steiner AA, Turek VF, Almeida MC, Burmeister JJ, Oliveira DL, Roberts JL, Bannon AW, Norman MH, Louis JC, Treanor JJS, Gavva NR, Romanovsky AA (2007) Nonthermal activation of transient receptor potential vanilloid-1 channels in abdominal viscera tonically inhibits autonomic cold-defense effectors. J Neurosci 27:7459-7468
31. Szallasi A (2006) Small molecule vanilloid TRPV1 receptor antagonists approaching drug status: can they live up to the expectations? Naunyn-Schmiedeberg's Arch Pharmacol 373:272-286
32. Szallasi A, Blumberg PM (1999) Vanilloid (capsaicin) receptors and mechanisms. Pharmacol Rev 51:159-212
33. Szallasi A, Blumberg PM, Annicelli LL, Krause JE, Cortright DN (1999) The cloned rat vanilloid receptor VR1 mediates both R-type binding and C-type calcium response in dorsal root ganglion neurons. Mol Pharmacol 56:581-587
34. Tominaga M, Caterina MJ, Malmberg AB, Rosen TA, Gilbert H, Skinner K, Raumann BE, Basbaum AI, Julius D (1998) The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 21:531-543
35. Toth A, Wang Y, Kedei N, Tran R, Pearce LV, Kang SU, Jin MK, Choi HK, Lee J, Blumberg PM (2005) Different vanilloid agonists cause different patterns of calcium response in CHO cells heterologously expressing rat TRPV1. Life Sci 76:2921-2932
36. Valenzano KJ, Grant ER, Wu G, Hachicha M, Schmid L, Tafesse L, Sun Q, Rotshteyn Y, Francis J, Limberis J, Malik S, Whittemore ER, Hodges D (2003) N-(4-tertiarybutylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine-1(2H) -carboxamide (BCTC), a novel orally effective vanilloid receptor 1 antagonist with analgesic properties: in vitro characterization and pharmacokinetic properties. J Pharmacol Exp Therap 306:377-386
37. Wang Y, Toth A, Tran R, Szabo T, Welter JD, Blumberg PM, Lee J, Kang SU, Lee J (2003) High affinity partial agonists of the vanilloid receptor. Mol Pharmacol 64:325-333
38. Wang Y, Kedei N, Wang M, Wang QJ, Huppler AR, Toth A, Tran R, Blumberg PM (2004) Interaction between protein kinase Cmu and the vanilloid receptor type 1. J Biol Chem 279:53674-53682
39. Westaway SM (2007) The potential of transient receptor potential vanilloid type 1 channel modulators for the treatment of pain. J Med Chem 50:2589-2596
40. Wrigglesworth R, Walpole CSJ, Bevan S, Campbell EA, Dray A, Hughes GA, James I, Masdin KJ, Winter J (1996) Analogues of capsaicin with agonist activity as novel analgesic agents: structure-activity studies. 4. Potent, orally active analgesics. J Med Chem 39:4942-4951
41. Zhang W, Victor RG (2000) Calcineurin inhibitors cause renal afferent activation in rats: a novel mechanism of cyclosporine-induced hypertension. Am J Hypertens 13:999-1004